Evidence map›Paper›PMID 42140932›Full record

ArticleNature communications2026

Asymmetric structural transitions in the icosahedral organization of Eastern equine encephalitis virus.

Abhishek Bandyopadhyay, Lauren E Williamson, Cameron D Buchman, Thomas Klose, James E Crowe, Richard J Kuhn

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abhishek BandyopadhyayDepartment of Biological Sciences, Purdue University, West Lafayette, IN, USA.ORCID http://orcid.org/0000-0001-7062-4343
Lauren E WilliamsonThe Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0002-2725-5826
Cameron D BuchmanThe Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, TN, USA.ORCID http://orcid.org/0000-0003-2550-649X
Thomas KloseDepartment of Biological Sciences, Purdue University, West Lafayette, IN, USA.ORCID http://orcid.org/0000-0002-2150-9792
James E CroweThe Vanderbilt Center for Antibody Therapeutics, Vanderbilt University Medical Center, Nashville, TN, USA. james.crowe@vumc.org.ORCID http://orcid.org/0000-0002-0049-1079
Richard J KuhnDepartment of Biological Sciences, Purdue University, West Lafayette, IN, USA. kuhnr@purdue.edu.ORCID http://orcid.org/0000-0003-4148-1026

Funding

Project 5: mAb Development Flaviviruses and AlphavirusesU19AI181960 · NIAID · WASHINGTON UNIVERSITY · PI DIAMOND, MICHAEL S, KUHN, RICHARD J. · 2024 to 2024
$46.7M
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The FilovirusesU19AI142790 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI SAPHIRE, ERICA OLLMANN · 2019 to 2023
$40.0M
Structural Studies of TogavirusesR01AI095366 · NIAID · PURDUE UNIVERSITY · PI KUHN, RICHARD J. · 2012 to 2023
$6.8M
Immunobiology of Blood and Vascular Systems Training ProgramT32HL069765 · NHLBI · VANDERBILT UNIVERSITY · PI HAWIGER, JACK J · 2002 to 2016
$6.5M
Human Monoclonal Antibodies for Encephalitic AlphavirusesR01AI172156 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI James E Crowe, Michael S Diamond · 2022 to 2026
$4.0M
Neutralization of Eastern equine encephalitis virus by human monoclonal antibodiesF31AI145189 · NIAID · VANDERBILT UNIVERSITY · PI WILLIAMSON, LAUREN · 2019 to 2020
$49k
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI095366-10Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI142790Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI172156Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) U19AI181960NHLBI NIH HHS T32 HL069765NIAID NIH HHS F31 AI145189NIAID NIH HHS HHSN272201700041INIAID NIH HHS R01 AI095366NIAID NIH HHS R01 AI172156NIAID NIH HHS U19 AI142790NIAID NIH HHS U19 AI181960
6 · The paper itself

Abstract

Delivery of the viral genome into host cells is a critical step in successful viral infection. Alphaviruses achieve this step by fusing the viral and endosomal membranes under acidic conditions. This process requires significant structural changes in the alphavirus glycoprotein organization. Structural characterization of acidic pH-induced conformational changes in alphavirus virions has remained elusive due to the rapid, transient nature of these states, conformational heterogeneity, and particle aggregation. Antibody binding studies conducted at elevated temperatures or under acidic pH conditions have further revealed the presence of transitional epitopes that are inaccessible on alphaviruses at room temperature or neutral pH. In this report, we present structural snapshots of the conformational changes in the glycoproteins and nucleocapsid core of a prototypical alphavirus, Eastern equine encephalitis virus, caused by exposure to 40 °C or pH 5.6. These findings provide insights into the structural transitions that occur prior to viral fusion with the endosomal membrane. This approach has also allowed us to define the molecular basis for recognition of a pan-alphavirus epitope by a patient-derived human antibody.

Indexed as

Encephalitis Virus, Eastern EquineAnimalsAntibodies, ViralEpitopesGlycoproteinsHumansHydrogen-Ion ConcentrationModels, MolecularNucleocapsidProtein ConformationVirionAntibodies, ViralEpitopesGlycoproteins

Identifiers

PMID42140932
PMCPMC13462590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.